Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events
Aim. Pharmacoeconomic analysis of apixaban use compared to conventional therapy in patients with venous thromboembolism (VTE).Material and methods. Economic evaluation was performed from a position of the health care system. The cost analysis, "cost-effectiveness" analysis, "impact on...
Saved in:
Main Author: | O. V. Shatalova (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events
by: O. V. Shatalova
Published: (2015) -
CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN
by: I. S. Yavelov
Published: (2015) -
Clinical utility of apixaban in the prevention and treatment of venous thromboembolism: current evidence
by: Zalpour A, et al.
Published: (2014) -
Apixaban role in the treatment of venous thromboembolic complications in patients with active cancer
by: E. P. Panchenko
Published: (2020) -
Efficacy and safety of venous thromboembolism prophylaxis with apixaban in major orthopedic surgery
by: Werth S, et al.
Published: (2012)